Trademark: 78502794
Word

Status
Dead
Status Code
710
Status Date
Friday, May 12, 2017
Serial Number
78502794
Registration Number
3152858
Registration Date
Tuesday, October 10, 2006
Mark Type
2000
Filing Date
Wednesday, October 20, 2004
Published for Opposition
Tuesday, July 18, 2006
Cancellation Date
Friday, May 12, 2017

Trademark Owner History
PAION DEUTSHLAND GMBH - Original Registrant
Paion GmbH - Original Applicant

Classifications
1 Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use
5 Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment[ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents;] medical and clinical diagnostic reagents for clinical or medical laboratory use
10 [Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration]
35 [Computerized database management, namely, processing data for third parties]
41 [Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics]
42 [Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ]preparation of expert opinions in the field of[ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry], product research and development of medical devices and pharmaceutical preparations, [and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries;] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products[; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment;] scientific research on and development of[ medical diagnostic equipment and] pharmaceutical preparations and products for the treatment of[ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases,] pain [and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment]
Color is not claimed as a feature of the mark.

Trademark Events
May 12, 2017
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Oct 10, 2015
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
May 20, 2013
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
May 20, 2013
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 4, 2013
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Apr 18, 2013
Case Assigned To Post Registration Paralegal
Apr 4, 2013
Teas Section 8 & 15 Received
Oct 10, 2006
Registered-Principal Register
Jul 18, 2006
Published For Opposition
Jun 28, 2006
Notice Of Publication
May 25, 2006
Law Office Publication Review Completed
May 19, 2006
Assigned To Lie
May 4, 2006
Approved For Pub - Principal Register
May 4, 2006
Examiner's Amendment Entered
May 4, 2006
Examiners Amendment E-Mailed
May 4, 2006
Examiners Amendment -Written
Apr 20, 2006
Amendment From Applicant Entered
Mar 23, 2006
Correspondence Received In Law Office
Mar 23, 2006
Paper Received
Feb 14, 2006
Report Completed Suspension Check Case Still Suspended
Aug 10, 2005
Letter Of Suspension E-Mailed
Aug 10, 2005
Suspension Letter Written
Aug 4, 2005
Amendment From Applicant Entered
Jul 27, 2005
Correspondence Received In Law Office
Jul 27, 2005
Paper Received
May 24, 2005
Non-Final Action E-Mailed
May 24, 2005
Non-Final Action Written
May 24, 2005
Assigned To Examiner
Oct 28, 2004
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24